Jeremy Grantham Sanofi Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $640,986 - $712,191	-14,100 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $5.06 Million - $5.76 Million	-111,642 Reduced 88.79%	14,100 $685,000
Q3 2020 Nov 13, 2020	SELL	$49.47 - $53.77 $8.69 Million - $9.44 Million	-175,600 Reduced 58.27%	125,742 $6.31 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $5.36 Million - $6.56 Million	-125,000 Reduced 29.32%	301,342 $15.4 Million
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $3.77 Million - $5.12 Million	-99,200 Reduced 18.88%	426,342 $18.6 Million
Q4 2019 Feb 13, 2020	SELL	$44.25 - $50.86 $2.36 Million - $2.72 Million	-53,400 Reduced 9.22%	525,542 $26.4 Million
Q3 2019 Nov 13, 2019	SELL	$40.34 - $46.64 $1.36 Million - $1.57 Million	-33,700 Reduced 5.5%	578,942 $26.8 Million
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $3.73 Million - $4.08 Million	92,200 Added 17.72%	612,642 $26.5 Million
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $293,976 - $327,096	-7,200 Reduced 1.36%	520,442 $23 Million
Q4 2018 Feb 13, 2019	SELL	$41.48 - $45.59 $165,920 - $182,360	-4,000 Reduced 0.75%	527,642 $22.9 Million
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $3.11 Million - $3.48 Million	77,714 Added 17.12%	531,642 $23.7 Million
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $518,240 - $567,681	-13,772 Reduced 2.94%	453,928 $18.2 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $18.2 Million - $21.4 Million	467,700 New	467,700 $18.7 Million

822

274M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.